Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 6/20 | 0.38 |
| ▸ | IDO1 | P14902 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | TTR | P02766 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | ERN1 | O75460 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL795694 | 0.93 | ERN1 (0.41) | AGXTIDO1CA1CA2PTGS2 | |
| Ether SCHEMBL8429378 | 0.89 | PTGS2 (0.36) | AGXTIDO1CA1CA2PTGS2 | |
| SCHEMBL10735808 | 0.89 | TTR (0.42) | AGXTIDO1TTRAPP | |
| SCHEMBL134443 | 0.86 | IDO1 (0.46) | AGXTIDO1PTGS2LMNATP53 | |
| Methyl Alcohol SCHEMBL28236652 | 0.80 | IDO1 (0.42) | AGXTIDO1PTGS2LMNATP53 | |
| SCHEMBL12650418 | 0.80 | AGXT (0.35) | AGXTIDO1CA1CA2TTR | |
| SCHEMBL31273 | 0.79 | IDO1 (0.58) | AGXTIDO1LMNAAPPALDH1A1 | |
| SCHEMBL4217287 | 0.78 | PTPN2 (0.38) | APP | |
| SCHEMBL8020885 | 0.78 | ESR1 (0.48) | AGXTIDO1CA2PTGS2LMNA | |
| SCHEMBL9679767 | 0.78 | TSHR (0.52) | AGXTIDO1CA1CA2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146112-A1 | PHOTO-MELT-BULK POLYMERIZATION FOR RECYCLABLE POLYDIENE-DERIVATIVES | PURDUE RESEARCH FOUNDATION (US) | 2026-05-28 | — | — | US | disclosed |
| US-20250302842-A1 | HETEROCYCLIC COMPOUNDS USEFUL FOR TREATMENT OF CANCERS | Jubilant Epipad LLC | 2025-10-02 | — | — | US | disclosed |
| EP-3630779-B1 | ANTIBIOTIC RESISTANCE BREAKERS | KING S COLLEGE LONDON (GB) | 2025-09-03 | — | — | EP | disclosed |
| US-12357639-B2 | Heterocyclic compounds as pad inhibitors | Jubilant Epipad LLC (US) | 2025-07-15 | — | — | US | disclosed |
| CN-115128898-B | Photosensitive resin composition and application thereof | 北京鼎材科技有限公司 | 2024-06-11 | — | — | CN | disclosed |
| US-20240156831-A1 | HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS | Jubilant Epipad LLC | 2024-05-16 | — | — | US | disclosed |
| EP-3684767-B1 | HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS | Jubilant Epipad LLC (US) | 2024-04-24 | — | — | EP | disclosed |
| US-11833156-B2 | Heterocyclic compounds as pad inhibitors | Jubilant Epipad LLC (US) | 2023-12-05 | — | — | US | disclosed |
| US-11746116-B2 | Antibiotic resistance breakers | KING'S COLLEGE LONDON (GB) | 2023-09-05 | — | — | US | disclosed |
| US-11746116-B2 | Antibiotic resistance breakers | KING'S COLLEGE LONDON (GB) | 2023-09-05 | — | — | US | disclosed |
| CN-110869373-A | Antibiotic resistance disruptors | 伦敦皇家学院 | 2020-03-06 | — | — | CN | disclosed |
| WO-2019058393-A1 | HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS | JUBILANT BIOSYS LIMITED (IN) | 2019-03-28 | — | — | WO | disclosed |
| US-10227588-B2 | 3′end caps for RNAi agents for use in RNA interference | NOVARTIS AG (CH) | 2019-03-12 | — | — | US | disclosed |
| US-9988627-B2 | Formats for organic compounds for use in RNA interference | NOVARTIS AG (CH) | 2018-06-05 | — | — | US | disclosed |
| US-8026370-B2 | Peroxisome proliferator antagonist; hyperlipemia agents; arteriosclerosis; antiischemic agents | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-09-27 | — | — | US | disclosed |
| US-20080167307-A1 | Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof | MITSUBISHI PHAMA CORPORATION (JP) | 2008-07-10 | — | — | US | disclosed |
| EP-1816128-A1 | CARBOXYLIC ACID DERIVATIVE CONTAINING THIAZOLE RING AND PHARMACEUTICAL USE THEREOF | Mitsubishi Pharma Corporation (JP) | 2007-08-08 | — | — | EP | disclosed |
| EP-0420941-B1 | PROCESS FOR PRODUCTION OF AROMATIC ALDOXIMES | ALLIED SIGNAL INC (US) | 1994-01-12 | — | — | EP | disclosed |
| EP-0420941-A1 | PROCESS FOR PRODUCTION OF AROMATIC ALDOXIMES. | ALLIED SIGNAL INC (US) | 1991-04-10 | — | — | EP | disclosed |
| WO-1989012623-A1 | PROCESS FOR PRODUCTION OF AROMATIC ALDOXIMES | ALLIED-SIGNAL INC. (US) | 1989-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167307-A1 | Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof | PPARA, PPARD, PPARG | AGXT 711/4885IDO1 4505/4885CA1 3375/4885 |
| US-11833156-B2 | Heterocyclic compounds as pad inhibitors | PADI4, PADI2, PADI1 | AGXT 673/4885IDO1 1631/4885CA1 1200/4885 |
| US-20250302842-A1 | HETEROCYCLIC COMPOUNDS USEFUL FOR TREATMENT OF CANCERS | NES, VHL, ETV6 | AGXT 4056/4885IDO1 3062/4885CA1 566/4885 |
| US-10227588-B2 | 3′end caps for RNAi agents for use in RNA interference | RNGTT, NSUN2, NSUN3 | AGXT 3556/4885IDO1 4611/4885CA1 4629/4885 |
| US-20240156831-A1 | HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS | PADI4, PADI2, PADI1 | AGXT 681/4885IDO1 872/4885CA1 2800/4885 |
| US-11746116-B2 | Antibiotic resistance breakers | ABCC1, ARL1, AKR1C3 | AGXT 302/4885IDO1 745/4885CA1 3072/4885 |
| US-12357639-B2 | Heterocyclic compounds as pad inhibitors | PADI4, PADI2, PADI1 | AGXT 681/4885IDO1 872/4885CA1 2800/4885 |
| US-20260146112-A1 | PHOTO-MELT-BULK POLYMERIZATION FOR RECYCLABLE POLYDIENE-DERIVATIVES | MUC1, PARP1, PARP2 | AGXT 4873/4885IDO1 3419/4885CA1 3855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.